MediMix Oncology
  • Home
  • Congresses
    • 2025
      • ESMO GI 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
ELCC 2024Lung Cancer

A network meta-analysis of perioperative IO for resectable NSCLC

4 April 2024

Yuelin Han, student at the Tongji Hospital, Wuhan, China presents a systematic review and network meta-analysis evaluating the the efficacy and safety of perioperative immunotherapy combinations for resectable NSCLC.

With the educational support of:

You may also be interested in:

The remaining challenges with neo-adjuvant immunotherapy in early-stage NSCLC

A propensity-based analysis of SBRT & VATS for early-stage lung cancer

Updated safety data of AEGEAN study

Tags:

poster

Share Article

Website created by MediMix © 2025 - Privacy Policy

  • Home
  • Congresses
    • 2025
      • ESMO GI 2025
      • ASCO 2025
      • ASCO GI 2025
      • ENETS 2025
      • ELCC 2025
      • EADO 2025
    • 2024
      • SABCS 2024
      • ESMO 2024
  • What’s new doc
    • Breast Cancer
    • GI Cancer
    • GU Cancer
    • Lung Cancer
  • Contact
  • Other specialties
    • Dermatology
    • Hematology
  • SIGN UP
  • SIGN IN
    • Login
    • Account
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok